2016 American Transplant Congress
IgM Treatment Successfully Prevents Type 1 Diabetes by Dysregulation of Pancreatic MicroRNAs with Immunomodulatory Roles.
Type 1 Diabetes (T1D) is hallmarked by beta-cells destruction. We aimed to identify specific pancreatic microRNAs (miRNA) as potential biomarkers for T1D prediction and diagnosis,…2016 American Transplant Congress
Pancreas Transplantation from Pediatric Donors: A UNOS Registry Analysis.
Division of Transplantation, University of Illinois at Chicago, Chicago.
Introduction: Major concerns about the utilization of pediatric pancreata are the cumulative islet mass and the increased technical complexity. The primary aim of this study…2016 American Transplant Congress
Impact of Early Hospital Readmission Following Simultaneous Pancreas Kidney Transplantation.
Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.
BACKGROUND: Our group recently demonstrated that 54% of simultaneous pancreas kidney (SPK) recipients experience early hospital readmission (EHR). It is unknown whether EHR following SPK…2016 American Transplant Congress
Simultaneous Pancreas and Kidney Transplantation for Type 2 Diabetes.
Transplantation, California Pacific Medical Center, San Francisco, CA.
Introduction: Type 2 diabetes (T2DM) is characterized initially by insulin resistance and later by beta cell failure. Historically, T2DM has been a relative contraindication for…2016 American Transplant Congress
Use of Integrated National Registry and Pharmacy Claims Data to Identify Diabetes Mellitus After Live Pancreas Donation.
Living donor pancreas transplant is a potential treatment for diabetic patients with end-organ complications. Early post-donation surgical risks of living pancreas donation have been reported,…2016 American Transplant Congress
Continuous Glucose Monitoring in the First 6 Weeks After Transplantation in Pancreas Transplant Recipients.
Introduction The maturation of Continuous glucose monitoring (CGM) technology enables accurate characterization of daily glucose control. We investigated glucose control using CGM in the first…2015 American Transplant Congress
Is BMI of 28 an Appropriate Cutoff for Simultaneous Pancreas Kidney Transplant in Type II Diabetes?
Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans, LA.
In simultaneous pancreas and kidney (SPK) transplantation, obesity has been reported to be associated with inferior survival and increased post-transplant complications. With implementation of the…2015 American Transplant Congress
Reconsideration of Age Limits for Pancreas Transplantation
Div. of Transplantation, Dept. of Surgery, University of Wisconsin, Madison, WI.
Introduction: Pancreas transplantation (PTx) remains the only strategy for reinstitution of long-term insulin production and outcomes have progressively improved. Yet, historically, centers have employed age-limits…2015 American Transplant Congress
Increased Use of Donors After Cardiac Death (DCD) in Pancreas Transplantation: A Safe and Effective Way to Increase a Single Center Program Activity
Multi-Organ Transplant, University Health Network, Toronto, ON, Canada.
The SRTR database shows that DCD donors are rarely used for pancreas transplantation in the USA (< 3% in 2010 -2012). This low rate likely…2015 American Transplant Congress
Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients
Surgery, The Ohio State University, Columbus, OH.
The present study evaluated the outcome of a Sirolimus based maintenance immunosuppressive protocol in pancreas transplant recipients. Between August 2003 and December 2013, a total…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- Next Page »